Innate Pharma certified as a Great Place to Work®

Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) today announced its certification as a great work place by the independent institute, Great Place to Work®, a global authority on workplace culture, employee experience and leadership behaviors. This recognition was based extensively on ratings provided by Innate Pharma's employees in an anonymous survey that assessed perspectives on leadership, organizational culture and trust. 

“We are very proud to have obtained the Great Place to Work certification, which acknowledges a high-performing and collaborative culture that attracts, engages and develops its employees," said Mondher Mahjoubi, Chief Executive Officer of Innate Pharma. “In the highly competitive biotech industry, our success depends on our ability to foster a positive company culture.  It’s rewarding to see the time, resources and energy we’ve committed around collaborating, listening and communicating to employees, reflected in our high levels of employee engagement and recognized by this external validation.”

Eighty-six percent of employees participated in the Great Place to Work survey process. Managerial practices, collaborative spirit, working conditions and commitment to the company were identified as main strengths of the company.  

"Congratulations to Innate Pharma for being one of the Great Place To Work® 2019 certified companies. This innovative company, with a strong social mission, has succeeded in getting employees to support its corporate culture and mission. As such, 90 percent of employees say they are ‘proud to tell others that they are working for Innate Pharma.’  Thus, the Great Place to Work® project, led by the company's highest level of management, contributes to making it a great place to work,”said Patrick Dumoulin, President of Great Place To Work® France.